65,437 trials
Aspergillus Infections · Candida Infections · Fungal Infections
Primary: Cmax of Voriconazole — 2433.7; 1997.0 ng/mL
Endometrial Cancer
Primary: Tolerability Measured Completion of Dose Regimen — 16 Participants
Asthma
Primary: For FS MDPI Versus Fp MDPI: Change From Baseline in 1-Hour Postdose Percent Predicted Morning Forced Expiratory Volume in 1 Second (FEV1) at Week 12 — 16.8; 16.4; 18.2…
Pain · Diabetic Peripheral Neuropathy
Primary: Mean Change in Average Daily Pain Score From Baseline Among Participants Who Received DS5565 for Pain Associated With Diabetic Peripheral Neuropathy — -0.59; -0.71…
Lymphoma · Leukemia, Lymphocytic, Chronic, B-Cell
Primary: Part 1: Number of Participants With Dose Limiting Toxicities (DLTs) — 0; 3; 1; 0 Participants
Type2 Diabetes
Primary: Number of PP-MI Sessions Completed by Participants — 7.4 sessions completed
Leukemia · Lymphoma
Primary: Number of Participants With Non-Relapse Mortality — 0 Participants
Common Cold
Primary: Number of Participants With Rhinovirus-associated Illness Episodes — 63; 60 Participants
Aortic Valve Stenosis
Primary: Number of Participants With Major Vascular Complications — 2; 1 Participants
Apnea of Prematurity · Respiratory Distress Syndrome
Primary: Number of Days on NCPAP or Mechanical Ventilation — 17.3; 12.3 days
Stress Disorders, Post-Traumatic
Primary: Clinician Administered PTSD Scale (CAPS-5) — 25.8; 31.0 score on a scale — p=0.002
Pulmonary Valve Insufficiency · Pulmonary Valve Degeneration · Congenital Pulmonary Valve Abnormality
Primary: Percentage of Subject's With Freedom From Device or Procedure Related Death and/or Reoperation at 1-year Post-implant. — 100.0 percentage of subjects
Colorectal Cancer
Primary: Average Area Under the Curve (AUC) for Numbness/Tingling Over 4 Months — 35.4; 31.5 Units on a scale *days
Prosthesis User · Amputation
Primary: 6 Minute Walk Test (6MWT) — 506; 428.23 Meters
Atrial Fibrillation
Primary: Number of Patients With Clinically-Significant Bleeding — 14; 17 Participants